Tumor physiologic response to combretastatin A4 phosphate assessed by MRI
Journal Article
·
· International Journal of Radiation Oncology, Biology and Physics
- Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX (United States)
Purpose: To evaluate the effect of the vascular targeting agent, combretastatin A4 phosphate, on tumor oxygenation compared with vascular perfusion/permeability. Methods and Materials: {sup 19}F MRI oximetry and dynamic contrast-enhanced (DCE)-MRI were used to monitor tumor oxygenation and perfusion/permeability in syngeneic 13762NF rat breast carcinoma. Results: A significant drop was found in the mean tumor pO{sub 2} (23 to 9 mm Hg, p <0.05) within 90 min after treatment (30 mg/kg of combretastatin A4 phosphate) and a further decrease was observed at 2 h (mean 2 mm Hg; p <0.01). The initial changes in pO{sub 2} in the central and peripheral regions were parallel, but by 24 h after treatment, a significant difference was apparent: the pO{sub 2} in the periphery had improved significantly, and the center remained hypoxic. These data are consistent with DCE-MRI, which revealed an {approx}70% decrease in perfusion/permeability (initial area under signal-intensity curve) at 2 h (p <0.001). The initial area under signal-intensity curve recovered fully after 24 h in a thin peripheral region, but not in the tumor center. Conclusion: The response observed by DCE-MRI, indicating vascular shutdown, paralleled the pO{sub 2} measurements as expected, but quantitative pO{sub 2} measurements are potentially important for optimizing the therapeutic combination of vascular targeting agents with radiotherapy.
- OSTI ID:
- 20698591
- Journal Information:
- International Journal of Radiation Oncology, Biology and Physics, Journal Name: International Journal of Radiation Oncology, Biology and Physics Journal Issue: 3 Vol. 62; ISSN IOBPD3; ISSN 0360-3016
- Country of Publication:
- United States
- Language:
- English
Similar Records
Assessment of Tumor Response to the Vascular Disrupting Agents 5,6-Dimethylxanthenone-4-Acetic Acid or Combretastatin-A4-Phosphate by Intrinsic Susceptibility Magnetic Resonance Imaging
Characterizing the Tumor Response to Treatment With Combretastatin A4 Phosphate
In Vivo Near-Infrared Spectroscopy and Magnetic Resonance Imaging Monitoring of Tumor Response to Combretastatin A-4-Phosphate Correlated With Therapeutic Outcome
Journal Article
·
Wed Nov 14 23:00:00 EST 2007
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:21039641
Characterizing the Tumor Response to Treatment With Combretastatin A4 Phosphate
Journal Article
·
Tue May 01 00:00:00 EDT 2007
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:20951635
In Vivo Near-Infrared Spectroscopy and Magnetic Resonance Imaging Monitoring of Tumor Response to Combretastatin A-4-Phosphate Correlated With Therapeutic Outcome
Journal Article
·
Wed Jun 01 00:00:00 EDT 2011
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:21491762